Paracetamol Safe in Pregnancy, Confirms MHRA After Major Lancet Review Finds No Autism or ADHD Risk
The UK medicines regulator MHRA reaffirmed paracetamol as safe during pregnancy after a major Lancet review found no link to autism, ADHD or intellectual disability in children.
UK MHRA | 20/01/2026 | By News Bureau
UK MHRA Approves up to 7.2 mg Dose of Semaglutide for Obesity Treatment
The UK MHRA has approved a higher dose of semaglutide of up to 7.2 mg for weight management in adult patients with obesity. The regimen involves three 2.4 mg injections and is indicated for use alongside a reduced-calorie diet and increased physical activity in adults with a Body Mass Index (BMI) of 30 kg/m² or higher.
UK MHRA | 17/01/2026 | By News Bureau
Aurobindo Pharma Wins UK MHRA Approval for Dazublys Trastuzumab Biosimilar
CuraTeQ Biologics, a wholly owned subsidiary of Aurobindo Pharma, has received marketing authorisation from the UK Medicines and Healthcare products Regulatory Agency (MHRA) for its trastuzumab biosimilar, Dazublys, used in the treatment of HER2-positive breast and gastric cancers.
UK MHRA | 27/08/2025 | By Darshana | 202
Marksans Pharma announces UK MHRA approval for Fluoxetine 20mg/5ml oral solution
The product will be manufactured at the plant of Bell, Sons & Co, UK
UK MHRA | 24/01/2023 | By Sudeep Soparkar | 562
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy